EDGC has been accredited by the College of American Pathologists (CAP) in the field of genetic testing using NGS and Microarray technology.

CAP accreditation is a certification program that examines and evaluates the accuracy, reliability and sustainability of clinical laboratory practices.

In particular, EDGC has been recognized for its technology and excellence by acquiring CAP accreditation for Direct-to-Consumer genetic testing(DTC) and its services using Microarray technology for the first time in Korea.